18th Mar 2009 07:00
Phorm, Inc. ("Phorm" or the "Company")
Change of Broker
Phorm (AIM: PHRM and PHRX), the advertising technology company, is pleased to announce the appointment of Evolution Securities Limited and Mirabaud Securities LLP as joint brokers, with immediate effect.
Canaccord Adams will continue as Phorm's nominated adviser.
End
For Phorm Enquiries:
Sarah Simon +44 20 7297 2433
David Sawday +44 780 1236499
Citigate Dewe Rogerson +44 20 7638 9571
Simon Rigby
Justin Griffiths
Canaccord Adams Limited +44 20 7050 6500
(Nominated Adviser)
Mark Williams
Andrew Chubb
Evolution Securities Limited
(Joint Broker)
Stuart Andrews +44 20 7071 4300
Adam Lloyd
Mirabaud Securities LLP
(Joint Broker)
Jason Woollard (Sales) +44 20 7866 0246
Rory Scott (ECM) +44 20 7878 3360
About Phorm:
Phorm is an innovative advertising technology company specialising in interest-based advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.
Phorm is a Delaware, US incorporated company, with offices in New York and London.
The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.
For more information, please visit: www.phorm.com
Related Shares:
PHRM.L